Case Report
A 53-year-old woman who had undergone aortic valve replacement with a S-E ball valve prosthesis (Model 1260, 9A, 23 mm) for aortic valve stenosis, together with open mitral co mmissurotomy for mitral stenosis, 28 years previously, was admitted to Kurume University Hospital because of worsening dyspnea on effort over the previous year. Auscultation of her heart disclosed a loud pansystolic murmur with prosthetic click, and a diastolic murmur characteristic of mitral stenosis at the apex of the heart. A chest X-ray showed marked cardiomegaly, and an electrocardiogram demonstrated inverted T wave in leads II, III, aVF and V1-6, as well as atrial fibrillation. Transesophageal echocardiography, including Doppler flow mapping, delineated the stenotic mitral orifice (mitral valva area 1.13 cm 2 ) with moderate mitral regurgitation, dilatation of the left atrium
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without thrombus, and severe tricuspid regurgitation. It also showed a normally functioning S-E prosthesis. Coronary angiograms revealed severe stenosis of the proximal right coronary artery and a normal left coronary artery; blood examination revealed no signs of hemolytic anemia. On the basis of these findings, bypass grafting to the right coronary artery, mitral valve replacement and tricuspid annuloplasty, as well as prophylactic replacement of the aortic S-E prosthetic valve, were scheduled.
The operation was performed through a median sternotomy. There was a palpable systolic thrill in the aortic root. Cardiopulmonary bypass was established by cannulation of the ascending aorta and both caval veins. After cardioplegic arrest, distal anastomosis of the right coronary artery with bypass grafting using autologous saphenous vein was perfomed. The aortic prosthetic valve was replaced with a 19 mm St Jude (SJM) bileaflet prosthesis (St Jude Medical, Heart Valve Division, St Paul, MN, USA); the mitral valve was replaced with a 27 mm SJM prosthesis via the transseptal approach, and tricuspid annuloplasty (TAP) by Kay's method was completed. The patient recovered uneventfully, and was discharged from the hospital 3 weeks after operation. An echocardiogram before discharge confirmed that the prosthetic valves were functioning normally. Postoperative visual and X-ray evaluation of the explanted S-E prosthesis revealed no abnormality other than lipid infiltration (Fig 1) .
Discussion
The S-E ball valve prosthesis was successfully introduced clinically in 1961-62 and since then has been widely used for aortic and mitral valve replacement. 4, 5 It is one of the artificial valves for which there are very long-term results; furthermore, the design of this prosthesis has remained basically unchanged over the years: Model 1260 is a caged ball with a sewn, cloth-covered ring and bare metal struts. McGoon et al reported that the S-E valve prosthesis was durable over a prolonged follow-up period, but that thromboembolism remained a persistent problem, 1 and Reichart et al also reported that it proved highly satisfactory in both the mitral and aortic positions in their latest (11-19 years) assessment of hemodynamic prosthetic valve function. 6 However, other authors have reported significant chronic hemolysis, thromboembolism, variance of the silastic ball and tissue ingrowth of the paravalvular area. 2, 3 In the present case, although the preoperative echocardiogram showed that the aortic S-E valve prosthesis that had been implanted 28 years previously was functioning normally, prophylactic replacement was perfomed at the same time as the mitral valve replacement, coronary artery bypass grafting and TAP. Grunkemeier and Starr suggested that prophylactic reoperation for S-E bare strut ball valves is not indicated in the current subset, 2 and Lund et al reported that S-E aortic ball valves, including the currently available silastic ball valves, are durable for the remaining life span of the patients who can expect near normal ageand sex-specific survival. 7 According to those reports, replacement of the aortic S-E ball prosthesis may not have been necessary; however, we replaced it because we believe that the hemodynamic function of the bileaflet SJM valve prosthesis, which we use currently, is better. 8, 9 In the present case it was not possible to measure accurately the preoperative left ventricular (LV) outflow gradient because the presence of the silastic ball meant that true axial flow was not achieved; therefore, the LV outflow gradients of the 23 mm S-E prosthesis and the 19 mm SJM prosthesis were not able to be compared. However, the postoperative echocardiographic examination showed remarkable improvement of LV function: the LV ejection fraction changed from 68% to 81%, LV mass index changed from 212 g/m 2 to 169 g/m 2 , LV end diastolic volume index changed from 87 ml/m 2 to 79 ml/m 2 and LV end systolic volume index changed from 34 ml/m 2 to 21 ml/m 2 .
The present report describes a rare opportunity for evaluation of an explanted S-E ball valve prosthesis that had been implanted 28 years previously. There was no abnormality other than of lipid infiltration of the silastic ball and no ball variance, demonstrating that the S-E ball valve is durable for at least 28 years in some patients.
